Sarepta Therapeutics Inc at Cowen Healthcare Conference (Virtual) Transcript
Hey, everyone. Thanks for joining us at the Sarepta fireside chat at the Cowen 2021 Health Care Conference. Hopefully, our first and only virtual health care conference for Cowen.
With us from Sarepta, we have CEO, Doug Ingram; CFO, Ian Estepan; and CMO, Gilmore O'Neill, who I'm sure most of you know.
Questions & Answers
So Doug, let's get started. I guess, Doug and Gilmore. So the last major milestone you have is the top line for the Phase II 102 study from your DMD gene therapy. You missed on the top line NSAA analysis because there's some pretty significant baseline imbalances between age cohorts, which were not stratified for baseline block. One question I've gotten from investors a lot is why didn't you stratify? And if you could, from there, just tell us how you're doing, what's the latest from the crossover patients and how
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
